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Editorial: dose-dependent ZnO particle-
induced acute phase response in humans
warrants re-evaluation of occupational
exposure limits for metal oxides
Ulla Vogel1,2* and Flemming R. Cassee3,4
Abstract
Epidemiological studies link inhalation of particles to increased risk of cardiovascular disease. Inhaled particles may induce
cardiovascular disease by several different mechanisms including translocation of particles to systemic circulation,
activation of airway sensory nerves resulting in autonomic imbalance and particle-induced pulmonary inflammation
and acute phase response.
The acute phase response is the systemic response to acute and chronic inflammatory states caused by for example
bacterial infection, virus infection, trauma and infarction. It is characterized by differential expression of ca. 50 different
acute phase proteins including C-reactive protein and Serum amyloid A, which are the most differentially up-regulated
acute phase response proteins. Blood levels of these two acute phase proteins are closely associated with risk of
cardiovascular disease in epidemiological studies and SAA has been causally related to the formation of plaques
in the aorta in animal studies.
In a recent paper in Particle and Fibre Toxicology, Christian Monsé et al. provide evidence that inhalation of ZnO
nanoparticles induces dose-dependent acute phase response in humans at dose levels well below the current
mass-based occupational exposure limits in a number of countries including Germany, The Netherlands, UK, Sweden,
Denmark and the US.
Given the evidence suggesting a causal relationship between increased levels of serum amyloid A and atherosclerosis,
the current results call for a re-evaluation of occupational exposure limits for a number of particle exposures including
ZnO taking induction of acute phase response into account. Furthermore, it underscores cardiovascular disease as an
occupational disease.
Epidemiological studies link inhalation of particles to
increased risk of cardiovascular disease [1]. Inhaled parti-
cles may induce cardiovascular disease by several different
mechanisms including translocation of particles to sys-
temic circulation, activation of airway sensory nerves
resulting in autonomic imbalance and particle-induced
pulmonary inflammation and acute phase response [2].
In a recent paper in Particle and Fibre Toxicology,
Christian Monsé et al. [3] provide evidence that inhalation
of ZnO nanoparticles induces dose-dependent acute phase
response in humans at dose levels well below the current
mass-based occupational exposure limits in some countries
including Denmark and the US. The acute phase response
is the systemic response to acute and chronic inflammatory
states caused by for example bacterial infection, virus infec-
tion, trauma and infarction [4]. It is characterized by differ-
ential expression of ca. 50 different acute phase proteins
including C-reactive protein (CRP) and Serum amyloid
A (SAA) which are the most differentially up-regulated
acute phase response proteins. Blood levels of these
two acute phase proteins are closely associated with
each other and with risk of cardiovascular disease in
epidemiological studies [5–7].
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The presence of SAA has been causally related to the
formation of plaques in the aorta. Overexpression of SAA
leads to increased plaque progression and inhibition of
SAA synthesis leads to lowered plaque progression in
APOE −/−mouse models [8, 9]. SAA plays an important
role in cholesterol transport. Under homeostasis, HDL fa-
cilities cholesterol transport from peripheral macrophages
to the liver. During the acute phase response, SAA is
incorporated into HDL lipoproteins, where it alters the
cholesterol flow, causing peripheral macrophages to accu-
mulate cholesterol and turn into foam cells, thus causing
plaque progression and atherosclerosis [10, 11]. SAA has
also been suggested to contribute to endothelial dysfunc-
tion, promote thrombosis, and enhance leukocyte traffick-
ing and activation [12]. On the other hand, there is little
evidence that CRP is causally related to risk of cardiovas-
cular disease. Mendelian randomization studies showed
that genetically determined differences in CRP levels were
not associated with risk of cardiovascular disease [13, 14].
Overall, this suggests that the acute phase response plays
a causal role in atherosclerosis. Even modest changes in
blood levels of SAA and CRP are associated with risk of
cardiovascular disease in humans. A 5-fold increase in
SAA levels was associated with 3-fold increased risk for
cardiovascular events defined as death from coronary
heart disease, nonfatal myocardial infarction or stroke,
or the need for coronary-revascularization procedures
in the Nurses’ Health Cohort [5].
In mice, inhalation and pulmonary exposure to a num-
ber of different nanoparticles and other particles has been
shown to induce long-lasting time and dose-dependent
pulmonary acute phase response [15, 16]. The pulmonary
acute phase response was shown to be proportional to the
total surface area of the pulmonary deposited particles
[15], neutrophil influx in the bronchoalveolar lavage fluid
[17] and to blood levels of SAA [18].
In humans, blood levels of acute phase proteins have
been shown to be associated with exposure to various
particle exposures including organic dust [19], dust from a
paper mill [20], welding fumes [21, 22] and fumes devel-
oped during firing of small weapons [23]. This suggests
that SAA and CRP levels may constitute sensitive and
robust biomarkers of particle-induced cardiovascular dis-
ease. Christian Monsé et al. show dose-dependent acute
phase response following a 4-h exposure to ZnO nanopar-
ticles at 0.5–2 mg/m3. SAA levels were statistically signifi-
cantly increased ca. 5 fold at 1 mg/m3 compared to sham
exposure. These levels are well below the occupational
exposure limit for ZnO which is 5–10 mg/m3 ZnO for
UK, Germany, The Netherlands, Sweden, Denmark and
the US (https://www.osha.gov/dts/chemicalsampling/data/
CH_277005.html) [24]. Moreover, exposure to welding
fumes with Zn and Cu also induced acute phase response
in human volunteers [22].
Given the evidence suggesting a causal relationship
between increased SAA levels and atherosclerosis, the
current results call for a re-evaluation of occupational
exposure limits for a number of particle exposures in-
cluding ZnO taking induction of acute phase response
into account. Furthermore, it underscores cardiovascular
disease as an occupational disease.
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